Literature DB >> 24100268

Reproductive endocrinology: Predictive biomarkers of pre-eclampsia in women with T1DM.

Baha M Sibai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24100268     DOI： 10.1038/nrendo.2013.191

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.

Authors:  C E Kleinrouweler; M M J Wiegerinck; C Ris-Stalpers; P M M Bossuyt; J A M van der Post; P von Dadelszen; B W J Mol; E Pajkrt
Journal:  BJOG       Date:  2012-03-20       Impact factor: 6.531

Review 2.  Hypertension in diabetic pregnancy: impact and long-term outlook.

Authors:  Antonietta Colatrella; Valentina Loguercio; Luca Mattei; Massimo Trappolini; Camilla Festa; Michela Stoppo; Angela Napoli
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-08       Impact factor: 4.690

3.  The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes.

Authors:  Keenan E Yanit; Jonathan M Snowden; Yvonne W Cheng; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2012-08-11       Impact factor: 8.661

4.  Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  B M Sibai; S Caritis; J Hauth; M Lindheimer; J P VanDorsten; C MacPherson; M Klebanoff; M Landon; M Miodovnik; R Paul; P Meis; M Dombrowski; G Thurnau; J Roberts; D McNellis
Journal:  Am J Obstet Gynecol       Date:  2000-02       Impact factor: 8.661

5.  Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women.

Authors:  Y Yu; A J Jenkins; A J Nankervis; K F Hanssen; H Scholz; T Henriksen; B Lorentzen; T Clausen; S K Garg; M K Menard; S M Hammad; J C Scardo; J R Stanley; A Dashti; K May; K Lu; C E Aston; J J Wang; S X Zhang; J-X Ma; T J Lyons
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

6.  Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial.

Authors:  David R McCance; Valerie A Holmes; Michael J A Maresh; Christopher C Patterson; James D Walker; Donald W M Pearson; Ian S Young
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

7.  Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Authors:  Robert W Powers; Arun Jeyabalan; Rebecca G Clifton; Peter Van Dorsten; John C Hauth; Mark A Klebanoff; Marshall D Lindheimer; Baha Sibai; Mark Landon; Menachem Miodovnik
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

8.  Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?

Authors:  Baha M Sibai; Matthew A Koch; Salvio Freire; Joao Luiz Pinto e Silva; Marilza Vieira Cunha Rudge; Sérgio Martins-Costa; Janet Bartz; Cleide de Barros Santos; Jose Guilherme Cecatti; Roberto Costa; José Geraldo Ramos; Joseph A Spinnato
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

Review 9.  Angiogenic factors and preeclampsia.

Authors:  Sharon E Maynard; S Ananth Karumanchi
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

10.  The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes.

Authors:  Valerie A Holmes; Ian S Young; Christopher C Patterson; Michael J A Maresh; Donald W M Pearson; James D Walker; David R McCance
Journal:  Diabetes Care       Date:  2013-08-06       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.